| Name | Title | Contact Details |
|---|
With a reputation as an innovative provider of quality care, Southwell is a growing, not-for-profit health system serving 12 counties in South Central Georgia. Southwell offers more than 135 physicians with expertise in over 30 specialties. Southwell provides a wide-range of care, including signature services in surgery, oncology, cardiovascular care, women`s health, neurodiagnostics, geriatric psychiatric care, radiology and more. The Main Campus is Tift Regional Medical Center, a 181-bed regional referral hospital located in Tifton. Our Tifton West Campus houses various diagnostic services and the region`s largest multi-specialty clinic. Our Cook County campus is anchored by Southwell Medical, an acute care facility which includes state-of-the-art surgical services and a 12-bed geriatric psychiatric unit. The Cook campus also includes Southwell Health and Rehabilitation, a 95-bed skilled rehabilitation facility.
Endependence Center is a Norfolk, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Autonomic Technologies is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Ascend Medical is a membership healthcare platform that provides patients with 24/7 provider access through end-to-end technology and convenient mobile visits that come to your home, work, or anywhere around town.